Ethylglucuronide as a potential marker for alcohol-induced elevation of urinary testosterone/epitestosterone ratios

Drug Testing and Analysis

Volumn 1, Issue 11-12, 2009, Pages 526-530

  Große, Joachim ^a   Anielski, Patricia ^a   Sachs, Hans ^b   Thieme, Detlef ^a  

^a Institute of Doping Analysis and Sports Biochemistry   (Germany)

^b Forensic Toxicological Centre   (Germany)

Author keywords

Doping analysis; Ethanol consumption; Ethylglucuronide; Steroid profile; Testosterone epitestosterone ratio

Indexed keywords

BLOOD; LIQUID CHROMATOGRAPHY;

ALCOHOL CONSUMPTION; DOPING ANALYSIS; ENDOGENOUS STEROIDS; ETHANOL CONSUMPTION; ETHYLGLUCURONIDE; LC-MS-MS; STEROID PROFILE; TANDEM-MASS SPECTROMETRY; TESTOSTERONE; TESTOSTERONE/EPITESTOSTERONE RATIO;

ETHANOL;

ALCOHOL; BIOLOGICAL MARKER; EPITESTOSTERONE; ETHYL GLUCURONIDE; TESTOSTERONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; DOPING; EPITESTOSTERONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; SCREENING; TESTOSTERONE URINE LEVEL; URINE LEVEL;

EID: 77953446423     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.110     Document Type: Article

References (13)

1. O. Falk, E. Palonek, I. Björkhem, Clin. Chem. 1988, 34, 1462.
2. T. Karila, V. Kosunen, A. Leinonen, R. Tähtelä, T. Seppälä, J. Chromatogr. B 1996, 687, 109.
3. U. Mareck-Engelke, H. Geyer, U. Schindler, U. Flenker, R. Iffland, M. Donike, in Recent Advances in Doping Analysis (3), (Eds:M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke), 1996, p. 143.
4. T. J. A. Seppenwolde-Waasdorp, D. de Boer, H. J. M. Van Engelen, A. D. Vrijdag, R. A. A. Maes, in Recent Advances in Doping Analysis (3), (Eds: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke), 1996, p. 147.
5. WADA Laboratory Committee. Reporting and Evaluation Guidance for Testosterone, Epitestosterone, T/E Ratio and Other Endogenous Steroids. World Anti-Doping Agency, Montreal, 2004, WADA Technical Document - TD2004EAAS.
6. World Anti-Doping Agency. Guideline - Reporting and Management of Elevated T/E Ratios. 2006, www.wada-ama.org/ rtecontent/document/ GuidelineReportingManagementElevated TERatios.pdf, accessed 25 June 2009.
7. F.M. Wurst, G. E. Skipper, W. Weinmann, Addiction 2003, 98, 51.
8. J. C. Kissack, J. Bishop,A. L. Roper, Pharmacotherapy 2008, 28, 769.
9. H. Geyer, W. Schänzer, U. Mareck-Engelke, E. Nolteernsting, G. Opfermann, in Recent Advances in Doping Analysis (5), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke), 1998, p. 99.
10. W. Weinmann, P. Schaefer, A. Thierauf, A. Schreiber, F. M. Wurst, J. Am. Soc.Mass Spectrom. 2004, 15, 188.
11. R. S. Foti, M. B. Fisher, Forensic Sci. Int. 2005, 153, 109.
12. J. J. Schulze, J. Lundmark, M. Garle, I. Skilving, L. Ekström, A. Rane, J. Clin. Endocrinol. Metab. 2008, 93, 2500.
13. H. Geyer, U. Mareck, N. Haenelt, W. Schänzer, in Recent Advances in Doping Analysis (17), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck), 2009, in press.